You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
欧药品管理局重申仍建议让长者接种阿斯利康疫苗
阿思达克 06-15 11:29
《路透》报道,欧洲药品管理局专责小组主管Marco Cavaleri表示,在权衡利害下,仍建议向所有年龄人士接种英国阿斯利康新冠疫苗,尤其为60岁以上长者。他指近日接受意大利《新闻报》(La Stampa)访问时,内容被误解。《新闻报》其後更改新闻标题及加入Cavaleri的澄清内容。

《新闻报》早前报道,Cavaleri指欧盟国家应避免对60岁以上长者及年青群组接种阿斯利康疫苗,基於担心血栓及有其他疫苗可供选择。多个欧盟成员国已停止向特定年龄组别人士接种阿斯利康疫苗,主要为50至65岁或以上人士。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account